Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura

Therapeutic Advances in Hematology

Volumn 6, Issue 3, 2015, Pages 97-102

  Khanal, Nabin ^a   Upadhyay, Smrity ^a   Dahal, Sumit ^b   Bhatt, Vijaya Raj ^c   Bierman, Philip J ^c  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b INTERFAITH MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

ADAMTS 13 deficiency; malignant hypertension; plasma exchange; renal failure; thrombocytopenia; thrombotic microangiopathy; thrombotic thrombocytopenic purpura

Indexed keywords

EID: 84993736115     PISSN: 20406207     EISSN: 20406215     Source Type: Journal    
DOI: 10.1177/2040620715571076     Document Type: Article

References (25)

1. Aggarwal M. Khan I. (2006) Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin 24: 135–146.
2. Akimoto T. Muto S. Ito C. Takahashi H. Takeda S. Ando Y. et al. (2011) Clinical features of malignant hypertension with thrombotic microangiopathy. Clin Exp Hypertens 33: 77–83.
3. Bawany M. Tariq Z. Sodeman T. Mutgi A. (2011) Malignant hypertension masquerading as thrombotic thrombocytopenic purpura. BJMP 4: a418.
4. Boctor F. Prichard J. (2009) Kidney involvement in thrombotic thrombocytopenic purpura and malignant hypertension. Transfusion 49: 1783–1784.
5. Deguchi I. Uchino A. Suzuki H. Tanahashi N. (2012) Malignant hypertension with reversible brainstem hypertensive encephalopathy and thrombotic microangiopathy. J Stroke Cerebrovasc Dis 21: 915, e917–e920.
6. Desai S. Clement J. Landaw S. (2008) A 51-year-old woman with shortness of breath and edema. Arthritis Rheum 59: 1184–1190.
7. Egan J. Bandarenko N. Hay S. Paradowski L. Goldberg R. Nickeleit V. et al. (2004) Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura. J Clin Apher 19: 125–129.
8. Ekberg M. Nilsson I. Hedner U. Moqvist I. Bergentz S. Denneberg T. (1974) Renal artery occlusion, malignant hypertension and thrombotic thrombocytopenic purpura. Acta Med Scand 195: 499–504.
9. Garewal M. Yahya S. Ward C. Singh N. Cruz-Flores S. (2007) MRI changes in thrombotic microangiopathy secondary to malignant hypertension. J Neuroimaging 17: 178–180.
10. George J. (2010) How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 116: 4060–4069.
11. Hunt B. Tueger S. Pattison J. Cavenagh J. D'Cruz D. (2007) Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus 16: 358–362.
12. Kadiri S. Olutade B. (1991) The clinical presentation of malignant hypertension in Nigerians. J Hum Hypertens 5: 339–343.
13. Li X. Zhang W. Ren H. Pan X. Chen N. (2009) Malignant hypertension complicated by acute renal failure. BMJ Case Rep 2009: 1–8.
14. Patel A. Patel H. Patel A. (2009) Thrombotic thrombocytopenic purpura: the masquerader. South Med J 102: 504–509.
15. Sarode R. Bandarenko N. Brecher M. Kiss J. Marques M. Szczepiorkowski Z. et al. (2014) Thrombotic thrombocytopenic purpura: 2012 American society for apheresis (Asfa) consensus conference on classification, diagnosis, management, and future research. J Clin Apher 29: 148–167.
16. Schauseil A. Rump L. Quack I. (2012) [Hypertensive emergency with clinical signs of a thrombotic microangiopathy]. Dtsch Med Wochenschr 137: 2476–2479.
17. Schwartz J. Winters J. Padmanabhan A. Balogun R. Delaney M. Linenberger M. et al. (2013) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: the sixth special issue. J Clin Apher 28: 145–284.
18. Shavit L. Reinus C. Slotki I. (2010) Severe renal failure and microangiopathic hemolysis induced by malignant hypertension–case series and review of literature. Clin Nephrol 73: 147–152.
19. Shibagaki Y. Fujita T. (2005) Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Hypertens Res 28: 89–95.
20. Strandgaard S. Paulson O. (1989) Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 2: 486–492.
21. van den Born B. Honnebier U. Koopmans R. van Montfrans G. (2005) Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension 45: 246–251.
22. van den Born B. van der Hoeven N. Groot E. Lenting P. Meijers J. Levi M. et al. (2008) Association between thrombotic microangiopathy and reduced adamts 13 activity in malignant hypertension. Hypertension 51: 862–866.
23. Wu Y. Chen X. Yang Y. Wang B. Liu X. Tao Y. et al. (2013) A case of lipoprotein glomerulopathy with thrombotic microangiopathy due to malignant hypertension. BMC Nephrol 14: 53.
24. Zampaglione B. Pascale C. Marchisio M. Cavallo-Perin P. (1996) Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 27: 144–147.
25. Zhang B. Xing C. Yu X. Sun B. Zhao X. Qian J. (2008) Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res 31: 479–483.